Oramed Appoints Dr. Anne Peters to its Scientific Advisory Board

NEW YORK , June 1, 2022 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced the appointment of Anne Peters , MD, to its Scientific Advisory Board .

Join our mailing list

Skip to content